Login
$ADAPY
$0.03 +$0.00 (3.08%) Close

$ADAPY 3 SEC Filings

Filed On Filing
08 Oct 2025 Form 3: Hill Christopher James, Chief Financial Officer

No securities owned

26 Mar 2024 Form 3: EcoR1 Capital, Llc, 10% owner

Holds 164,424,420 shares of Ordinary Shares

01 Nov 2023 Form 3: Hege Kristen, Director
01 Jun 2023 Form 3: Menzel Garry E, Director

No securities owned

01 Jun 2023 Form 3: Hegde Priti, Director

No securities owned

01 Jun 2023 Form 3: Allen Andrew R, Director

No securities owned

04 May 2022 Form 3: Brewer Joanna Elizabeth, Chief Scientific Officer

No securities owned

31 Jan 2022 Form 3: Piccina Cintia, Chief Commercial Officer

No securities owned

01 Apr 2020 Form 3: Wood Gavin, Chief Financial Officer

No securities owned

13 Jan 2020 Form 3: Norry Elliot, Chief Medical Officer

Holds 2,679 shares of Ordinary Shares with a nominal value of GBP0.001 per share

01 Oct 2019 Form 3: Garone Michael, Interim CFO

No securities owned

05 Aug 2019 Form 3: Lunger John, Chief Patient Supply Officer

Holds 28,806 shares of Ordinary Shares with a nominal value of GBP0.001 per share

06 Jul 2018 Form 3: Furey John, Director
15 Mar 2017 Form 3: Bertrand William C Jr, Chief Operating Officer
28 Nov 2016 Form 3: Zaks Tal Zvi, Director

No securities owned

28 Nov 2016 Form 3: Kerr Giles Francis Bertram, Director

No securities owned

23 Jun 2016 Form 3: Duncan Barbara Gayle, Director
04 Jan 2016 Form 3: Alleva Lawrence M, Director

Holds 70,584 shares of Ordinary Shares with a nominal value of GBP0.001 per share

04 Jan 2016 Form 3: Thompson Peter A., Director

Holds 25,408,300 shares of Ordinary Shares with a nominal value of GBP0.001 per share

04 Jan 2016 Form 3: Knowles Jonathan Kenneth Charles, Director

Holds 7,067,600 shares of Ordinary Shares with a nominal value of GBP0.001 per share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support